Showing results (151-160 of 157) with videos related to
Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 157 results.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|September 9, 2016
RAIDD Mediates TLR3 and IRF7 Driven Type I Interferon ProductionSathish Kumar Maney, Haifeng C Xu, Jun Huang, et al.Proceedings of the National Academy of Sciences of the United States of America|October 8, 2014
Mapping of transcription factor motifs in active chromatin identifies IRF5 as key regulator in classical Hodgkin lymphomaStephan Kreher, M Amine Bouhlel, Pierre Cauchy, et al.Immunity, Inflammation and Disease|January 25, 2024
Presence of neutralizing SARS-CoV-2 antibodies in asymptomatic population of N'Djamena, ChadAndrillene Laure Deutou Wondeu, Mahamat Fayiz Abakar, Federica Frasca, et al.ACS Infectious Diseases|October 18, 2021
Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of ConcernMadalina Elena Carter-Timofte, Rozanne Arulanandam, Naziia Kurmasheva, et al.Nature Communications|October 3, 2020
SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarateDavid Olagnier, Ensieh Farahani, Jacob Thyrsted, et al.Nature Communications|October 22, 2020
Author Correction: SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarateDavid Olagnier, Ensieh Farahani, Jacob Thyrsted, et al.Nature Communications|May 15, 2024
Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathwaysNaziia Kurmasheva, Aida Said, Boaz Wong, et al.Pageof 16